OREXIGEN THERAPEUTICS INC's ticker is and the CUSIP is 686164904. A total of 4 filers reported holding OREXIGEN THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $12,000 | -91.9% | 27,500 | -89.6% | 0.00% | -100.0% |
| Q1 2016 | $149,000 | -75.4% | 265,100 | -24.6% | 0.00% | -71.4% |
| Q4 2015 | $605,000 | +14.8% | 351,600 | +40.9% | 0.01% | 0.0% |
| Q3 2015 | $527,000 | -79.7% | 249,600 | -52.4% | 0.01% | -80.6% |
| Q2 2015 | $2,594,000 | -50.2% | 524,100 | -21.1% | 0.04% | -56.1% |
| Q1 2015 | $5,204,000 | +172.6% | 664,600 | +111.0% | 0.08% | +182.8% |
| Q4 2014 | $1,909,000 | +26.0% | 315,000 | -11.4% | 0.03% | +26.1% |
| Q3 2014 | $1,515,000 | -36.0% | 355,700 | -7.2% | 0.02% | -36.1% |
| Q2 2014 | $2,369,000 | +10.0% | 383,300 | +15.7% | 0.04% | 0.0% |
| Q1 2014 | $2,153,000 | -13.3% | 331,300 | -24.9% | 0.04% | -2.7% |
| Q4 2013 | $2,483,000 | +29.1% | 441,000 | +40.7% | 0.04% | 0.0% |
| Q3 2013 | $1,924,000 | +131.2% | 313,400 | +120.2% | 0.04% | +76.2% |
| Q2 2013 | $832,000 | – | 142,300 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|